CLINICAL_TRIALS
trial_result
· 2015-07-13
Clinical Trial Update: Anfibatide Treatment in STEMI Patients [Phase 2]
Summary
Phase 2 trial update on Anfibatide for ST-segment elevation myocardial infarction; current status is UNKNOWN.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Lee's Pharmaceutical Limited | Conditions: ST Segment Elevation Myocardial Infarction | Phase 2 | Status: UNKNOWN